The Ambey Laboratories IPO subscription status started on July 04, 2024, and QIB, NII, and RII are also subscribing to it. The Ambey Laboratories IPO opens on July 04, 2024, and will end on July 08, 2024. Ambey Laboratories IPO is preparing to raise ₹44.68 crores through its fresh issue and offer for sale, in which the fresh issue is ₹42.55 crores and the offer for sale is ₹2.12 crores, and the Ambey Laboratories IPO price band is fixed ₹65 to ₹68 per share. You Can check Ambey Laboratories IPO GMP here.
Ambey Laboratories, incorporated in 1985, manufactures agrochemical products for crop protection. The company has been serving the agrochemical sector for almost four decades. The company manufactures and supplies 2,4-D base chemicals. The company’s manufacturing facility is in Behror, Rajasthan.
The company currently produces the following products for its customer base: large corporates like Aromatic Rasayan Private Limited, JR Jindal Infraprojects Private Limited, and SC Formulator Co. Ltd.
Ambey Laboratories IPO reserved shares in this IPO, 50% for QIB 15% for NII, and 35% for the retail category have been reserved. To know the Ambey Laboratories IPO Subscription Status, you can see the below-day Subscription.
Ambey Laboratories IPO Review :
Show Review…….
- ■ The company is engaged in the business of agrochemical products manufacturing and marketing.
- ■ The company top & Bottom line posted inconsistency report.
- ■ The PE ratio of the company is slightly high.
- ■ Based on FY24 annualized super earnings, the issue appears aggressively priced.
- ■ The company Issue price is slightly aggressive based on the PE Ratio.
Ambey Laboratories IPO Subscription Status {Live Update} :
Ambey Laboratories IPO Subscription Status has subscribed 42.75x times so far, with QIB subscribed 0.41x NII subscribed 50.39x times & RII 64.90x times on Day 2.
The Subscription data live fetching every minute by exchanges. Click the Refresh button to reload the table.
Day 2
The final subscription data is added automatically below the table after the day ends at 7:00 P.m.
| Category | Day 1 | Day 2 | Day 3 |
| QIB : | 0.41x | 0.41x | x |
| NII : | 19.86x | 50.39x | x |
| RII : | 28.80x | 64.90x | x |
| Total : | 18.96x | 42.75x | x |
Ambey Laboratories IPO Net Shares Offered:
Ambey Laboratories IPO is a public issue of 6,244,001 equity shares. The issue offers 1,252,000 shares to qualified institutional buyers, 606,001 shares to non-institutional investors, and 2,184,000 shares to retail investors.
| Category | Reservation | Net EQ Offer | Amount(in Cr) |
|---|---|---|---|
| Anchor : | 29.98% | 1,872,000 | 12.73 |
| QIB : | 20.05% | 1,252,000 | 8.51 |
| NII : | 9.71% | 606,001 | 4.12 |
| RII : | 34.98% | 2,184,000 | 14.85 |
| MMRP : | 5.29% | 330,000 | 2.24 |
| Total : | 100% | 6,244,001 | 42.46 |
Investor Categories Define :
■ Qualified Institutional Buyers (QIB): Financial Institutions, Banks, FIIs, Mutual Funds, insurance companies, and pension schemes.
■ Non-Institutional Investors(NII): Retail Individual Investors, NRIs, Companies, Trusts, etc
● sNII (bids below Rs 10L): The Small NII category is for NII investors who bid for shares between Rs 2 lakhs to Rs 10 lakhs. The 1/3 of NII category shares are reserved for the Small NII sub-category.
● bNII (bids above Rs 10L): The Big NII category is for NII investors who bid for shares worth more than Rs 10 Lakhs. The 2/3 of NII category shares are reserved for the Big NII subcategory.
■ Retail Individual Investors (RII): Retail Individual Investors or NRIs
■ Employee (EMP): Eligible Employees
■ Others: Eligible Shareholders
Ambey Laboratories IPO Subscription Status FAQs :
How much is the total Ambey Laboratories IPO Subscription Status?
The total Ambey Laboratories IPO Subscription Status is 42.75x times Day 2.
What is the Ambey Laboratories IPO retail subscription Status?
Ambey Laboratories IPO Retail Subscription 64.90x times Day 2.
What is the Ambey Laboratories IPO QIB subscription Status?
The Ambey Laboratories IPO QIB subscription is 0.41x times Day 2.
What is the Ambey Laboratories IPO NII subscription status?
Ambey Laboratories IPO NII Subscription 50.39x times Day 2.
When is the Ambey Laboratories IPO Allotment Date?
Ambey Laboratories IPO allotment date is July 09, 2024.
When is Ambey Laboratories IPO Listing Date?
Ambey Laboratories IPO listing date is July 11, 2024. The IPO is to be listed on NSE, SME.
How to Apply the Ambey Laboratories IPO through Zerodha?
Log in to the Console on the Zerodha Website. Go to Portfolio and Click on IPO. You will see the IPO Name “Ambey Laboratories IPO”. Click on the Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate.
How to Apply the Ambey Laboratories IPO through Upstox?
Log in to the Upstox Website or app. Go to Portfolio and Click on IPO. You will see the IPO Name “Ambey Laboratories IPO”. Click on the Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate.
How to Apply the Ambey Laboratories IPO through Groww?
Log in to the Groww Website or app. Now you can see IPOs and Click on IPO. You will see the IPO Name “Ambey Laboratories IPO”. Click on the Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate.
How to Apply the Ambey Laboratories IPO through Paytm Money?
Log in to the Paytm Money Website or app. Now you can see Invest in IPOs Section and Click on IPO. You will see the IPO Name “Ambey Laboratories IPO”. Click on the Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate.
| Ambey Laboratories IPO GMP: Click Here Ambey Laboratories IPO Details: Click Here Ambey Laboratories IPO Allotment: Click Here Ambey Laboratories IPO Listing: Click Here |
All Ambey Laboratories IPO-related links are available here. If you want to know the details then click on the Click Here Link.
Disclaimer: STOCK MARKET INVESTMENTS ARE SUBJECT TO MARKET RISKS, READ ALL SCHEME-RELATED DOCUMENTS CAREFULLY BEFORE INVESTING.